With high levels of uptake, cervical screening commencement at age 20 and the ability to link individual screening and vaccination records, we are able, in Scotland, to demonstrate definitively the early impact of bivalent HPV vaccine on HPV infections in the target population.
In fact, the higher level of cervical intraepithelial neoplasia detected in the colposcopy arms attests to the probability of overdetection and overtreatment, although the extent of this remains unclear.
This is supported by evidence of high levels of PAHs in cervical mucus and cervical tissue among smokers [ 38].
High levels of participation in cervical screening are reported in Canada from the 1970's as a result of early uptake of the Pap smear and universal Medicare.
In contrast, our findings for total oestradiol, SHBG, oestrone, and free oestradiol fail to support the notion that high levels of oestrogens increase the risk of cervical cancer.
Only 19.6%% of the women showed high levels of awareness with respect to cervical cancer, especially the mode of transmission, the main cause, and the symptoms.
High levels of HPV 16 correctly predicted cervical intraepithelial neoplasia (CIN) grade II-III in 93% of its occurrences, but only 59% of cases of CIN III were associated with high levels of this type.
This suggested that high levels of CA-IX expression in cervical glandular cells may serve as a useful biomarker for diagnosing conventional glandular lesions (CGLs) of the cervix, including AIS and adenocarcinoma (Liao et al, 1994, 2009; Liao and Stanbridge, 1996, 2000).
We thus propose that women with high levels of PAO and/or DAO in their cervical mucus may be at increased risk of cervical cancer, especially if the male partner's SP shows high polyamine levels.
Compared to low exposure, women living in census tracts with high levels of PAHs had an increased prevalence of cervical dysplasia (aOR = 2.46, 95% CI: 1.35-4.48).
